{"paper_id":"824a6a9c-2cb9-4ac7-8a13-510d4f2b19f1","body_text":"Abstract\nStudies have examined how endometriosis interacts with the nervous System, but little attention has been paid to opioidergic Systems, which are relevant to pain signaling. We used the autotransplantation rat model of endometriosis and allowed to progress for 60 days. The brain was collected and examined for changes in endogenous Opioid peptides, mu Opioid receptors (MORs), and the N-methyl-D-aspartate subunit receptor (NRI) in the periaqueductal gray (PAG), since both of these receptors can regulate PAG activity. No changes in endogenous Opioid peptides in met- and leu-enkephalin or ß-endorphin levels were observed within the PAG. However, MOR immunoreactivity was significantly decreased in the ventral PAG in the endometriosis group. Endometriosis reduced by 20% the number of neuronal profiles expressing MOR and reduced by 40% the NRI profiles. Our results suggest that endometriosis is associated with subtle variations in opioidergic and glutamatergic activity within the PAG, which may have implications for pain processing.\nSimilar content being viewed by others\nReferences\nBulun SE. Endometriosis. N Engl J Med. 2009;360(3):268–279.\nMoawad NS, Caplin A. Diagnosis, management, and long-term outcomes of rectovaginal endometriosis. Int J Womens Health. 2013;5:753–763.\nRogers PA, D’Hooghe TM, Fazleabas A, et al.. Defining future directions for endometriosis research:Workshop report from the 2011 World Congress of Endometriosis In Montpellier, France. Reprod Sci. 2013;20(5):483–499.\nBarnack JL, Chrisler JC. The experience of chronic illness in women:a comparison between women with endometriosis and women with chronic migraine headaches. Women Health. 2007; 46(1):115–133.\nFourquet J, Baez L, Figueroa M, Iriarte RI, Flores I. Quantification of the impact of endometriosis Symptoms on health-related quality of life and work productivity. Fertil Steril. 2011;96(1):107–112.\nFourquet J, Gao X, Zavala D, et al.. Patients’ report on how endometriosis affects health, work, and daily life. Fertil Steril. 2010; 93(7):2424–2428.\nBrawn J, Morotti M, Zondervan KT, Becker CM, Vincent K. Central changes associated with chronic pelvic pain and endometriosis. Hum Reprod Update. 2014;20(5):737–747.\nAs-Sanie S, Harris RE, Napadow V, et al.. Changes in regional gray matter volume in women with chronic pelvic pain:a voxel-based morphometry study. Pain. 2012;153(5):1006–1014.\nTracey I, Mantyh PW. The cerebral signature for pain perception and its modulation. Neuron. 2007;55(3):377–391.\nMcAllister SL, Dmitrieva N, Berkley KJ. Sprouted innervation into uterine transplants contributes to the development of hyper-algesia in a rat model of endometriosis. PLoS One. 2012;7(2):e31758.\nStratton P, Berkley KJ. Chronic pelvic pain and endometriosis:translational evidence of the relationship and implications. Hum Reprod Update. 2011;17(3):327–346.\nCuevas M, Flores I, Thompson KJ, Ramos-Ortolaza DL, Torres-Reveron A, Appleyard CB. Stress exacerbates endometriosis manifestations and inflammatory parameters in an animal model. Reprod Sci. 2012;19(8):851–862.\nBandler R, Shipley MT. Columnar Organization in the midbrain periaqueductal gray:modules for emotional expression? Trends Neurosci. 1994;17(9):379–389.\nVianna DM, Borelli KG, Ferreira-Netto C, Macedo CE, Brandao ML. Fos-like immunoreactive neurons following electrical Stimulation of the dorsal periaqueductal gray at freezing and escape thresholds. Brain Res Bull. 2003;62(3):179–189.\nYu R, Gollub RL, Spaeth R, Napadow V, Wasan A, Kong J. Disrupted functional Connectivity of the periaqueductal gray in chronic low back pain. Neuroimage Clin. 2014;6:100–108.\nMainero C, Louapre C. Migraine and inhibitory System-I can’t hold it! Curr Pain Headache Rep. 2014;18(7):426.\nChadha HK, Armstrong JE, Mo wer GD, Hubscher CH. Effects of surgical induction of endometriosis on response properties of pre-optic area neurons in rats. Brain Res. 2008;1246:101–110.\nBach FW, Yaksh TL. Release into ventriculo-cisternal perfusate of beta-endorphin- and Met-enkephalin-immunoreactivity:effects of electrical Stimulation in the arcuate nucleus and periaqueductal gray of the rat. Brain Res. 1995;690(2):167–176.\nBach FW, Yaksh TL. Release of beta-endorphin immunoreactiv-ity from brain by activation of a hypothalamic N-methyl-D-aspartate receptor. Neuroscience. 1995;65(3):775–783.\nTerashvili M, Tseng LF, Wu HE, et al.. Antinociception produced by 14,15-epoxyeicosatrienoic acid is mediated by the activation of beta-endorphin and met-enkephalin in the rat ventrolateral periaqueductal gray. J Pharmacol Exp Ther. 2008;326(2):614–622.\nMoss MS, Basbaum AI. The fine structure of the caudal periaqueductal gray of the cat:morphology and synaptic Organization of normal and immunoreactive enkephalin-labeled profiles. Brain Res. 1983;289(1-2):27–43.\nFinley JC, Lindstrom P, Petrusz P. Immunocytochemical loca-lization of beta-endorphin-containing neurons in the rat brain. Neuroendocrinology. 1981;33(1):28–42.\nFinley JC, Maderdrut JL, Petrusz P. The immunocytochemical localization of enkephalin in the central nervous System of the rat. J Comp Neurol. 1981;198(4):541–565.\nVercellini P, Sacerdote P, Panerai AE, Manfredi B, Bocciolone L, Crosignani G. Mononuclear cell beta-endorphin concentration in women with and without endometriosis. Obstet Gynecol. 1992; 79(5 pt l):743–746.\nRodriguez-Munoz M, Sanchez-Blazquez P, Vicente-Sanchez A, Berrocoso E, Garzon J. The mu-opioid receptor and the NMDA receptor associate in PAG neurons:implications in pain control. Neuropsychopharmacology. 2012;37(2):338–349.\nCommons KG, van Bockstaele EJ, Pfaff DW. Frequent colocali-zation of mu Opioid and NMDA-type glutamate receptors at post-synaptic sites in periaqueductal gray neurons. J Comp Neurol. 1999;408(4):549–559.\nGhelardini C, Galeotti N, Vivoli E, et al.. Molecular interaction in the mouse PAG between NMDA and Opioid receptors in morphine-induced acute thermal nociception. J Neurochem. 2008;105(1):91–100.\nAppleyard CB, Cruz ML, Hernandez S, Thompson KJ, Bayona M, Flores I. Stress management affects outcomes in the pathophysiol-ogy of an endometriosis model. Reprod Sci. 2015;22(4):431–441.\nVernon MW, Wilson EA. Studies on the surgical induction of endometriosis in the rat. Fertil Steril. 1985;44(5):684–694.\nAppleyard CB, Cruz ML, Rivera E, Hernandez GA, Flores I. Experimental endometriosis in the rat is correlated with colonic motor funetion alterations but not with bacterial load. Reprod Sci. 2007;14(8):815–824.\nOcio EM, Vilanova D, Atadja P, et al.. In vitro and in vivo rationale for the triple combination of panobinostat (LBH589) and dexamethasone with either bortezomib or lenalidomide in multiple myeloma. Haematologica. 2010;95(5):794–803.\nMilner TA, Drake CT. Ultrastructural evidence for presynaptic mu Opioid receptor modulation of synaptic plasticity in NMDA-receptor-containing dendrites in the dentate gyrus. Brain Res Bull. 2001;54(2):131–140.\nRoh DH, Seo HS, Yoon SY, et al.. Activation of spinal alpha-2 adrenoceptors, but not mu-opioid receptors, reduces the intrathe-cal N-methyl-D-aspartate-induced increase in spinal NR1 subunit phosphorylation and nociceptive behaviors in the rat. Anesthesia and analgesia. 2010;110:622–629.\nArvidsson U, Riedl M, Chakrabarti S, et al.. The kappa-opioid receptor is primarily postsynaptic:combined immunohistochem-ical localization of the receptor and endogenous Opioids. Proc Natl Acad Sci USA. 1995;92:5062–5066.\nAbbadie C, Gultekin SH, Pasternak GW. Immunohistochemical localization of the carboxy terminus of the novel mu Opioid receptor splice variant MOR-1C within the human spinal cord. Neu-roreport. 2000;11:1953–1957.\nDrake CT, Milner TA. Mu Opioid receptors are in somatodendritic and axonal compartments of GABAergic neurons in rat hippo-campal formation. Brain Res. 1999;849:203–215.\nKasai S, Yamamoto H, Kamegaya E, et al.. Quantitative detection of micro Opioid receptor:Western blot analyses using micro Opioid receptor knockout mice. Curr Neuropharmacol. 2011; 9(1):219–222.\nGarzon J, Juarros JL, Castro MA, Sanchez-Blazquez P. Antibodies to the cloned mu-opioid receptor detect various molecular weight forms in areas of mouse brain. Mol Pharmacol. 1995; 47(4):738–744.\nChen W, McRoberts JA, Marvizon JC. mu-Opioid receptor inhi-bition of substance P release from primary afferents disappears in neuropathic pain but not inflammatory pain. Neuroscience. 2014; 267:67–82.\nSiegel SJ, Brose N, Janssen WG, et al.. Regional, cellular, and ultrastructural distribution of N-methyl-D-aspartate receptor subunit 1 in monkey hippocampus. Proc Natl Acad Sci USA. 1994; 91:564–568.\nCheng PY, Svingos AL, Wang H, et al.. Ultrastructural immuno-labeling shows prominent presynaptic vesicular localization of delta-opioid receptor within both enkephalin- and nonenkephalin-containing axon terminals in the superficial layers of the rat cervi-cal spinal cord. J Neurosci. 1995;15(9):5976–5988.\nSvingos AL, Clarke CL, Pickel VM. Cellular sites for activation of delta-opioid receptors in the rat nucleus accumbens shell:rela-tionship with Met5-enkephalin. J Neurosci. 1998; 18(5):1923–1933.\nHsu SM, Raine L, Fanger H. A comparative study of the peroxidase-antiperoxidase method and an avidin-biotin complex method for studying Polypeptide hormones with radioimmunoas-say antibodies. Am J Clin Pathol. 1981;75(5):734–738.\nPierce JP, Kurucz OS, Milner TA. Morphometry of a peptidergic transmitter System:dynorphin B-like immunoreactivity in the rat hippocampal mossy fiber pathway before and after seizures. Hippocampus. 1999;9(3):255–276.\nWaters EM, Torres-Reveron A, McEwen BS, Milner TA. Ultrastructural localization of extranuclear progestin receptors in the rat hippocampal formation. J Comp Neurol. 2008; 511(1):34–46.\nPaxinos G, Watson C. The Rat Brain Atlas in Stereotaxic Coor-dinates. 2nd ed. Philadelphia, PA:Elsevier, Inc; 1986.\nNakamura NH, McEwen BS. Changes in interneuronal pheno-types regulated by estradiol in the adult rat hippocampus:a potential role for neuropeptide Y. Neuroscience. 2005;136(1):357–369.\nTorres-Reveron A, Williams TJ, Chapleau JD, et al.. Ovarian Steroids alter mu Opioid receptor trafficking in hippocampal parval-bumin GABAergic interneurons. Exp Neurol. 2009;219(1):319–327.\nCohen J. Statistical Power Analysis for the Behavioral Sciences. 2nd ed. Hillsdale, NJ:Laurence Earlbaum Associates; 1988.\nMurakami S, Okamura H, Yanaihara C, Yanaihara N, Ibata Y. Immunocytochemical distribution of met-enkephalin-Arg6-Gly7-Leu8 in the rat lower brainstem. J Comp Neurol. 1987;261(2):193–208.\nKow LM, Commons KG, Ogawa S, Pfaff DW. Potentiation of the excitatory action of NMDA in ventrolateral periaqueductal gray by the mu-opioid receptor agonist, DAMGO. Brain Res. 2002; 935(1-2):87–102.\nSimsek Y, Gul M, Yilmaz E, Ozerol IH, Ozerol E, Parlakpinar H. Atorvastatin exerts anti-nociceptive activity and decreases serum levels of high-sensitivity C-reactive protein and rumor necrosis factora in a rat endometriosis model. Arch Gynecol Obstet. 2014 Nov;290(5):999–1006.\nNagabukuro H, Berkley KJ. Influence of endometriosis on viscer-omotor and cardiovascular responses induced by vaginal disten-tion in the rat. Pain. 2007;132(suppl I):s96-sl03.\nMcAllister SL, McGinty KA, Resuehr D, Berkley KJ. Endometriosis-induced vaginal hyperalgesia in the rat:role of the ectopic growths and their innervation. Pain. 2009;147(1-3):255–264.\nFyfe LW, Cleary DR, Macey TA, Morgan MM, Ingram SL. Tol-erance to the antinocieeptive effect of morphine in the absence of short-term presynaptic desensitization in rat periaqueductal gray neurons. J Pharmacol Exp Ther. 2010;335(3):674–680.\nBagley EE, Chieng BC, Christie MJ, Connor M. Opioid tolerance in periaqueductal gray neurons isolated from mice chronically treated with morphine. Br J Pharmacol. 2005;146(1):68–76.\nLoyd DR, Murphy AZ. The role of the periaqueductal gray in the modulation of pain in males and females:are the anatomy and physiology really that different? Neural Plast. 2009;2009:462879.\nBabst R, Bongiorno L, Marini M, et al.. Age-induced increase of leucine enkephalin enzyme degradation in human plasma. Peptides. 1998;19(7):1155–1163.\nStaud R. Abnormal endogenous pain modulation is a shared char-acteristic of many chronic pain conditions. Expert Rev Neurother. 2012;12(5):577–585.\nWouters MM, Boeckxstaens GE. Neuroimmune mechanisms in functional bowel disorders. Neth J Med. 2011;69(2):55–61.\nAuthor information\nAuthors and Affiliations\nCorresponding author\nRights and permissions\nAbout this article\nCite this article\nTorres-Reverón, A., Palermo, K., Hernández-López, A. et al. Endometriosis Is Associated With a Shift in MU Opioid and NMDA Receptor Expression in the Brain Periaqueductal Gray. Reprod. Sci. 23, 1158–1167 (2016). https://doi.org/10.1177/1933719116630410\nPublished:\nIssue date:\nDOI: https://doi.org/10.1177/1933719116630410","source_license":"CC0","license_restricted":false}